The Effect of Continuous, Various Doses of Furosemide Drip on Hearing as Measured by Acoustic Emission
Recruitment status was: Not yet recruiting
Pediatric patients, during their illness often treated with furosemide (Lasix) continuous drip, often, with dosages above 4-6mg/kg/day (the recommended dose).
This study will monitor hearing status of these children prior to their therapy with furosemide, during this therapy and after.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||The Effect of Continuous, Various Dosages of Furosemide Drip on Hearing as Measured by Acoustic Emission|
|Study Start Date:||August 2009|
|Estimated Study Completion Date:||August 2010|
This study will record hearing status, by acoustic emission, of critically ill children, treated with different dosages of furosemide drip.
Acoustic emission test will be done prior to therapy and q48 hours during their course of treatment with furosemide drip.
Dosage of furosemide drip, boluses and other relevant medications (i.e - vancomycin, muscular relaxants, aminoglycosides etc) will be recorded.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00945386
|Contact: Elhanan - Nahum, MD||972 3 firstname.lastname@example.org|
|Contact: Miriam Davidowitz, MD||972 3 7253666|
|Pediatric ICU, Schneider Children's Hospital||Not yet recruiting|
|Petah Tikva, Israel, 49202|
|Contact: elhanan Nahum, MD 97239253686 email@example.com|
|Contact: Gili Kadmon, MD 97239253686 firstname.lastname@example.org|
|Principal Investigator: Elhanan Nahum, MD|
|Principal Investigator: Miriam Dawidowitz, MD|
|Sub-Investigator: Gili Kadmon, MD|
|Sub-Investigator: Offer Schiller, MD|
|Study Director:||Elhanan Nahum, MD||Schneider Children's Hospital|